Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $221.89 Million |
|---|---|
| Enterprise Value | $220.66 Million |
| Earnings per Share | $0.3 |
| Beta | -0.04 |
| Outstanding Shares | 19,199,029 |
| P/E Ratio | 58.42 |
|---|---|
| PEG | -47.5 |
| Price to Sales | - |
| Price to Book Ratio | 1.07 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -65.77 |
| Enterprise Value to Net Income | 50 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 22.63%▼ 65.69% |
|---|---|
| Total Invested | $46.78M▼ 74.22% |
| Investors Holding | 20▼ 31.00% |
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or m...